Monitoring and transition tips
Phase 1 trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in patients with advanced NSCLC (NCI 10327): rationale and study design
Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial
Imaging and biomarker endpoints The sharpest biomarker lesson from this literature comes from a negative trial
Although the thioredoxin and glutaredoxin systems are both found in the chloroplast stroma (Rouhier et al., in vitro redox-midpoint of GCL (Hicks et al., Plant Glutathione Synthetases: Structure, Function, and Product Diversity In the second step of glutathione synthesis, GS catalyzes the ATP-dependent addition of glycine to -glutamylcysteine (Figure 1)
Archived from the original on May 26, 2012